DNA copy number alterations in prostate cancers: A combined analysis of published CGH studies

Identifying genomic regions that are commonly deleted or gained in neoplastic cells is an important approach to identify tumor suppressor genes and oncogenes. Studies in the last two decades have identified a number of common DNA copy number alterations in prostate cancer. However, because of various sample sizes, diverse tumor types and sources, as well as a variety of detection methods with various sensitivities and resolutions, it is difficult to summarize and fully interpret the overall results.

[1]  Ajay N. Jain,et al.  High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays. , 2003, The American journal of pathology.

[2]  T. Shuin,et al.  Detection of genetic alterations in advanced prostate cancer by comparative genomic hybridization. , 2002, Cancer genetics and cytogenetics.

[3]  H. Tanke,et al.  Identification of Genetic Markers for Prostatic Cancer Progression , 2000, Laboratory Investigation.

[4]  Tapio Visakorpi,et al.  Genetic aberrations in prostate cancer by microarray analysis , 2006, International journal of cancer.

[5]  Mariël Brok,et al.  Deletion of chromosomal region 6q14‐16 in prostate cancer , 2002, International journal of cancer.

[6]  Yutaka Miura,et al.  Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer , 2005, Nature Genetics.

[7]  Jorma Isola,et al.  In vivo amplification of the androgen receptor gene and progression of human prostate cancer , 1995, Nature Genetics.

[8]  A. Ashworth,et al.  Genome-wide screening for genetic changes in a matched pair of benign and prostate cancer cell lines using array CGH , 2005, Prostate Cancer and Prostatic Diseases.

[9]  K. Junker,et al.  Gain in chromosome 8q correlates with early progression in hormonal treated prostate cancer. , 2002, European urology.

[10]  A. Evans,et al.  Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement. , 2006, Neoplasia.

[11]  Hongjuan Zhao,et al.  Genome‐wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines , 2005, The Prostate.

[12]  R. Vessella,et al.  KLF5 is frequently deleted and down‐regulated but rarely mutated in prostate cancer , 2003, The Prostate.

[13]  J. Schleutker,et al.  Androgen receptor gene alterations and chromosomal gains and losses in prostate carcinomas appearing during finasteride treatment for benign prostatic hyperplasia. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  T. Visakorpi,et al.  Genetic alterations in hormone-refractory recurrent prostate carcinomas. , 1998, The American journal of pathology.

[15]  H. Moch,et al.  Genetic changes in clinically organ-confined prostate cancer by comparative genomic hybridization. , 2000, Urology.

[16]  M. Banerjee,et al.  A similar pattern of chromosomal alterations in prostate cancers from African-Americans and Caucasian Americans. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  Jin-Tang Dong.  Chromosomal Deletions and Tumor Suppressor Genes in Prostate Cancer , 2004, Cancer and Metastasis Reviews.

[18]  P. Carroll,et al.  Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. , 1996, Cancer research.

[19]  M. Meyerson,et al.  Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. , 2005, Cancer research.

[20]  A. Brothman,et al.  Multiple abnormalities detected by dye reversal genomic microarrays in prostate cancer: a much greater sensitivity than conventional cytogenetics. , 2004, Cancer genetics and cytogenetics.

[21]  R. Vessella,et al.  Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization , 2002, Genes, chromosomes & cancer.

[22]  C. Larsson,et al.  5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines , 2001, Genes, chromosomes & cancer.

[23]  D. Johnston,et al.  Genetic markers useful for distinguishing between organ‐confined and locally advanced prostate cancer , 2003, Genes, chromosomes & cancer.

[24]  H. Tanke,et al.  Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic features. , 2001, The American journal of pathology.

[25]  J. Squire,et al.  Resolution of genotypic heterogeneity in prostate tumors using polymerase chain reaction and comparative genomic hybridization on microdissected carcinoma and prostatic intraepithelial neoplasia foci. , 2002, Cancer genetics and cytogenetics.

[26]  T. Visakorpi,et al.  Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model. , 1997, British Journal of Cancer.

[27]  Richard A. King,et al.  The genetic basis of common diseases. , 2002 .

[28]  Kenny Q. Ye,et al.  Large-Scale Copy Number Polymorphism in the Human Genome , 2004, Science.

[29]  M. Skolnick,et al.  Microdissection, DOP-PCR, and comparative genomic hybridization of paraffin-embedded familial prostate cancers. , 2000, Cancer genetics and cytogenetics.

[30]  L. Chu,et al.  Genetic abnormalities specifically associated with varying metastatic potential of prostate cancer cell lines as detected by comparative genomic hybridization. , 2001, Cancer genetics and cytogenetics.

[31]  R. Bookstein,et al.  Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer , 1994, Genes, chromosomes & cancer.

[32]  B. Wullich,et al.  Novel amplification unit at chromosome 3q25–q27 in human prostate cancer , 2000, The Prostate.

[33]  Jianfeng Xu,et al.  Germline copy number polymorphisms involving larger than 100 kb are uncommon in normal subjects , 2007, The Prostate.

[34]  J. Sebat,et al.  Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. , 2003, Genome research.

[35]  H. Moch,et al.  Discovery of new DNA amplification loci in prostate cancer by comparative genomic hybridization * , 2001, The Prostate.

[36]  H. Klocker,et al.  Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: Association with progression and angiogenesis , 2004, The Prostate.

[37]  R. Vessella,et al.  Comparative genomic hybridization and molecular cytogenetic characterization of two prostate cancer xenografts , 1997, Genes, chromosomes & cancer.

[38]  A. Lapuk,et al.  Construction and application of a full‐coverage, high‐resolution, human chromosome 8q genomic microarray for comparative genomic hybridization , 2005, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[39]  Jane Fridlyand,et al.  Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors , 2004 .

[40]  H. van Dekken,et al.  DNA in situ hybridization (interphase cytogenetics) versus comparative genomic hybridization (CGH) in human cancer: detection of numerical and structural chromosome aberrations. , 2000, Acta histochemica.

[41]  D. Bostwick,et al.  Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. , 1997, Cancer research.

[42]  J. Tchinda,et al.  TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. , 2006, Cancer research.

[43]  Robert Henke,et al.  High-resolution identification of chromosomal abnormalities using oligonucleotide arrays containing 116,204 SNPs. , 2005, American journal of human genetics.

[44]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[45]  T. Mattfeldt,et al.  Chromosomal changes in incidental prostatic carcinomas detected by comparative genomic hybridization. , 2002, European urology.

[46]  Jianfeng Xu,et al.  Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping array , 2006, Genes, chromosomes & cancer.

[47]  T. Mattfeldt,et al.  Genetic changes in stage pT2N0 prostate cancer studied by comparative genomic hybridization , 2002, BJU international.

[48]  B. Wullich,et al.  Comparative genomic hybridization reveals DNA copy number gains to frequently occur in human prostate cancer , 1999, The Prostate.

[49]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[50]  H. Höfler,et al.  Chromosomal changes during development and progression of prostate adenocarcinomas , 2001, British Journal of Cancer.

[51]  J. Schleutker,et al.  Genetic changes in familial prostate cancer by comparative genomic hybridization , 2001, The Prostate.

[52]  C. Collins,et al.  High‐resolution array comparative genomic hybridization of chromosome arm 8q: Evaluation of genetic progression markers for prostate cancer , 2005, Genes, chromosomes & cancer.

[53]  R. Lothe,et al.  Genomic analysis of prostate carcinoma specimens obtained via ultrasound‐guided needle biopsy may be of use in preoperative decision‐making , 2004, Cancer.

[54]  J. Veltman,et al.  Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines , 2004, Genes, chromosomes & cancer.

[55]  T. Visakorpi,et al.  Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization. , 1998, Cancer genetics and cytogenetics.

[56]  Stefan Joos,et al.  Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization , 1995, Genes, chromosomes & cancer.

[57]  D. Pinkel,et al.  Evaluation of genetic patterns in different tumor areas of intermediate‐grade prostatic adenocarcinomas by high‐resolution genomic array analysis , 2004, Genes, chromosomes & cancer.

[58]  K. Naito,et al.  Accuracy of an array comparative genomic hybridization (CGH) technique in detecting DNA copy number aberrations: comparison with conventional CGH and loss of heterozygosity analysis in prostate cancer. , 2004, Cancer genetics and cytogenetics.

[59]  T. Visakorpi,et al.  Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. , 1995, Cancer research.